Live Breaking News & Updates on Clinical Laboratory Medicine

Stay updated with breaking news from Clinical laboratory medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glycomimetics wilts on missed acute myeloid leukemia phase III

Top-line data from Glycomimetics Inc.’s pivotal phase III study of uproleselan in 388 patients with relapsed/refractory acute myeloid leukemia missed its primary endpoint. The data crippled the stock, which closed at the low point of its 10-year existence. ....

Glycomimetics Inc , Glycomimetics Inc , Acute Myeloid Leukemia , Fast Track Designation , Breakthrough Therapy , Small Molecule ,

Lyra sinks as rhinosinusitis drug-device misses in phase III

Less than a week ago, executives at Lyra Therapeutics Inc. were looking ahead to “imminent” data from its first phase III study in chronic rhinosinusitis (CRS), testing drug-device candidate LYR-210, a drug-device candidate largely expected to fill a much-needed gap in CRS treatment. On Monday, May 6, they were announcing plans to preserve cash in the wake of the failed Enlighten 1 study, which raised doubts as to the feasibility of the company’s CRS programs, which also include the similarly designed candidate LYR-220. ....

Lyra Therapeutics Inc , Lyra Therapeutics , Lyr 220 , Lyra Therapeutics Inc , Bioworld Medtech , Combination Drug Device , Lyr 210 , Mometasone Furoate , Chronic Rhinosinusitis ,